UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for untreatable liver cancer
Disease control Recruiting nowThis study tests whether adding a targeted procedure (TACE) to a standard drug (lenvatinib) works better than the drug alone for people with liver cancer that cannot be removed by surgery. About 40 adults aged 18-75 with early to advanced liver cancer will be enrolled. The goal i…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
New radiation bead injection targets untreatable liver tumors
Disease control Recruiting nowThis early-stage study tests a single injection of MDN-001 (yttrium-90 microspheres) in 40 adults with liver cancer that cannot be surgically removed. The tiny radioactive beads are delivered directly to the tumor to destroy cancer cells from within. The main goals are to check s…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE1 • Sponsor: Suzhou Mednovo Yi Medical Technology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:28 UTC